Echo Therapeutics Announces Positive Results From Symphony(TM) Transdermal Continuous Glucose Monitoring System Study At Tufts Medical Center
Echo Therapeutics (OTC Bulletin Board: ECTE) announced positive results from its clinical study of the Symphony(TM) tCGM System, a novel, non-invasive, transdermal continuous glucose monitoring (tCGM) system, conducted at the Tufts Medical Center in Boston, Massachusetts (Tufts).
More: continued here
Filed under: Diabetes on March 15th, 2008